Sheffield University Enterprises Limited (SUEL)
The Innovation Centre, 217 Portobello, Sheffield S1 4DP
Telephone 0114 222 4330, Facsimile 0114 222 4430
Email: info@suel.co.uk, Web: www.suel.co.uk
 
SUEL  / News Items


Sheffield SIFE
BioFusion Licensing
University spin-out company sold to US firm
Formed to develop a new drug to stop cancer tumour
Lifestyle Choices Launch Plan Ahead
NPI Ventures
Genophrenix Ltd
£420,000 Axordia Investment
Plasso Technology Ltd
Biofusion Plc
Proof of Concept Fund
DTI Competition
Biofusion Ltd
Sheffield Polymer Centre
SHC
Latest News
Sheffield SIFE
Sheffield SIFE Runners Up in the 2008 competition
BioFusion Licensing
Biofusion Licensing
  
Biofusion Image

Biofusion plc successful IPO launch

Biofusion plc ("Biofusion" or the "Company") today announces it has published its Admission Document relating to an £8.2m fundraising (the "Placing") and to the admission of all of the Company's ordinary shares to trading on AIM ("Admission"), which is expected to take place on Wednesday 2 February 2005. The new ordinary shares are being placed with institutional investors at 150p per share, raising approximately £8.2m and giving the Company a market capitalisation of approximately £28.2m immediately following Admission. Biofusion was established in 2002 to commercialise university-generated intellectual property ("IP") and has signed a ten year exclusive arrangement with the University of Sheffield for the commercialisation of IP owned by the University in the area of medical life sciences. Commenting on today's announcement, Doug Liversidge, the Chairman of Biofusion said: "We are delighted to have successfully completed our IPO. We are already working closely with the University of Sheffield to generate value from its IP in the medical life science sectors and the spin-off companies that have already been created. The capital we have now raised will be used to finance the development of these companies and to establish and develop new portfolio companies. We are confident this will allow us to generate considerable value for shareholders and we look forward to our future as a listed company." Professor Bob Boucher, (Former) Vice-Chancellor of the University of Sheffield, said: "Biofusion's successful IPO marks an important day for the University of Sheffield. The Biofusion model has huge potential for commercialisation of university-based research, and it fits well with current Government and university thinking on fostering innovation from within the academic community." Contacts: Biofusion Doug Liversidge - +44 (0) 7798 892918 David Baynes - +44 (0) 7976 351896 Peter Grant - +44 (0) 7768 255440 Citigate Dewe Rogerson Chris Gardner/David Dible - +44 (0) 20 7638 9571 Code Securities Phil Walker - +44 (0) 20 7024 2003 University of Sheffield Jon Pyle - +44 (0)114 222 1038
SUEL home logo